Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics

If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics

from Moneycontrol Business News https://www.moneycontrol.com/news/business/exclusive-|-goldman-sachs-private-equitytalks-to-buy-minority-stakeipo-bound-biocon-biologics_14328581.html